Skip to Content

A-101 Approval Status

  • FDA approved: No
  • Brand name: A-101
  • Generic name: hydrogen peroxide
  • Dosage form: Topical Solution
  • Company: Aclaris Therapeutics, Inc.
  • Treatment for: Seborrheic Dermatitis

A-101 (hydrogen peroxide) 40% topical solution is a proprietary, high-concentration hydrogen peroxide formulation for the treatment of seborrheic keratosis (SK).

Development Status and FDA Approval Process for A-101

DateArticle
May  9, 2017FDA Accepts Aclaris Therapeutics’ New Drug Application for Topical Treatment of Seborrheic Keratosis, a Common Skin Condition
Feb 27, 2017Aclaris Therapeutics Submits New Drug Application for A-101 as a Novel Treatment for Seborrheic Keratosis – a Common Skin Condition
Nov 15, 2016Aclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertreated Skin Condition

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide